Fibroblast growth factor 10 (FGF10) ameliorates pulmonary arterial hypertension by restoring endothelial mitochondrial function and reducing DNA damage via the PPARγ pathway
Suhong Lu, Nan Wang, Yingying Zhou, Ting Ran, Qingqing Deng, Hongyu Zhang et al. Fibroblast growth factor 10 (FGF10) ameliorates pulmonary arterial hypertension by restoring endothelial mitochondrial function and reducing DNA damage via the PPARγ pathway. // Vascular Pharmacology. – 2026. – DOI: 10.1016/j.vph.2026.107714. – URL: https://doi.org/10.1016/j.vph.2026.107714
Suhong Lu, Nan Wang, Yingying Zhou, Ting Ran, Qingqing Deng, Hongyu Zhang, Xuekui Du, & Xiaoxia Kong (2026). Fibroblast growth factor 10 (FGF10) ameliorates pulmonary arterial hypertension by restoring endothelial mitochondrial function and reducing DNA damage via the PPARγ pathway. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2026.107714
Suhong Lu, et al. “Fibroblast growth factor 10 (FGF10) ameliorates pulmonary arterial hypertension by restoring endothelial mitochondrial function and reducing DNA damage via the PPARγ pathway.” Vascular Pharmacology, 2026. doi:10.1016/j.vph.2026.107714.
@article{Lu2026,
title = {Fibroblast growth factor 10 (FGF10) ameliorates pulmonary arterial hypertension by restoring endothelial mitochondrial function and reducing DNA damage via the PPARγ pathway},
author = {Lu, Suhong and Wang, Nan and Zhou, Yingying and Ran, Ting and Deng, Qingqing and Zhang, Hongyu and Du, Xuekui and Kong, Xiaoxia},
journal = {Vascular Pharmacology},
year = {2026},
doi = {10.1016/j.vph.2026.107714},
url = {https://doi.org/10.1016/j.vph.2026.107714}
}